| Thrombosis at Unusual Sites: Focus on Myeloproliferative Neoplasms and Paroxysmal Nocturnal Hemoglobinuria |
|
Hamostaseologie |
Myeloproliferative Neoplasms (MPN), Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Use of Immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis |
|
Haemotologica |
Myelodysplastic Syndromes (MDS) |
| Towards graft- versus-host disease-free alternative donor transplant platforms for patients with acquired aplastic anemia |
|
Haematologica |
Aplastic Anemia, Graft Versus Host Disease (GVHD) |
| Significant hemolysis is not required for thrombosis in paroxysmal nocturnal hemoglobinuria. |
|
Haematologica |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Understanding pharmacological complement inhibition in paroxysmal nocturnal hemoglobinuria |
|
Haematologica |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy |
|
Haematologica |
Aplastic Anemia |
| Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria |
|
Haematologica |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Understanding infectious complications in patients with lower risk myelodysplastic syndromes: a step towards improving survival |
|
Haematologica |
Myelodysplastic Syndromes (MDS) |
| Granulocyte transfusions in severe aplastic anemia |
|
Haematologica |
Aplastic Anemia |
| Germline and somatic genetic landscape of pediatric myelodysplastic syndromes |
|
Haematologica |
Myelodysplastic Syndromes (MDS) |
